Skip to main content
Top

Current Cardiology Reports

Issue 8/2020

Content (24 Articles)

Metabolic Regulation of Human Pluripotent Stem Cell-Derived Cardiomyocyte Maturation

  • Regenerative Medicine (SM Wu, Section Editor)

Christopher A. P. Batho, Richard J. Mills, James E. Hudson

Reprogramming of Non-myocytes into Cardiomyocyte-like Cells: Challenges and Opportunities

  • Birth
  • Regenerative Medicine (SM Wu, Section Editor)

Gregory Farber, Li Qian

Modeling Congenital Heart Disease Using Pluripotent Stem Cells

  • Regenerative Medicine (SM Wu, Section Editor)

Arun Sharma

Pluripotent Stem Cell Modeling of Anticancer Therapy–Induced Cardiotoxicity

Davi M. Lyra-Leite, Paul W. Burridge

Artificial Intelligence-Enabled ECG: a Modern Lens on an Old Technology

Anthony H. Kashou, Adam M. May, Peter A. Noseworthy

Can Anticoagulation Be Stopped After Ablation of Atrial Fibrillation?

Jackson J. Liang, David J. Callans

Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020

  • Colchicine
  • Pericardial Disease (AL Klein and CL Jellis, Section Editors)

Enrico Tombetti, Alice Mulè, Silvia Tamanini, Luca Matteucci, Enrica Negro, Antonio Brucato, Carla Carnovale

Erdheim-Chester Disease: a Rare but Important Cause of Recurrent Pericarditis

Johnny Chahine, Jafar Alzubi, Hanan Alnajjar, Jay Ramchand, Michael Chetrit, Allan L. Klein

Overview of Optimal Techniques for Pericardiocentesis in Contemporary Practice

  • Echocardiography
  • Pericardial Disease (AL Klein and CL Jellis, Section Editors)

Sushil Allen Luis, Garvan C. Kane, Chris R. Luis, Jae K. Oh, Lawrence J. Sinak

The Role of MRI in Prognostic Stratification of Cardiomyopathies

  • Cardiomyopathy
  • Myocardial Disease (A Abbate and G Sinagra, Section Editors)

Chrysanthos Grigoratos, Giancarlo Todiere, Andrea Barison, Giovanni Donato Aquaro

Heart and Brain: Complex Relationships for Left Ventricular Dysfunction

Gianlorenzo Daniele, Stephanie DiLucia, Pier-Giorgio Masci, Federica del Monte

Ischemia and Viability Testing in New-Onset Heart Failure

Kameel Kassab, Ajoe John Kattoor, Rami Doukky

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity

  • Open Access
  • Anthracycline
  • Nuclear Cardiology (V Dilsizian, Section Editor)

Jothilingam Sivapackiam, Monica Sharma, Thomas H. Schindler, Vijay Sharma

The Effects of Lower BP Goals on Cognitive Function in the Elderly

  • Perindopril
  • Hypertension (DS Geller and DL Cohen, Section Editor)

Zeke Zamora, Jeff D. Williamson

Barbershop Management of Hypertension in the African American Population: Pitfalls and Opportunities for Extension to Other Underserved Communities

  • Hypertension
  • Hypertension (DS Geller and DL Cohen, Section Editor)

Joseph Ebinger, Ciantel A. Blyler, Jeffrey Brettler, Florian Rader

Artificial Intelligence and Myocardial Contrast Enhancement Pattern

Fang Tang, Chen Bai, Xin-Xiang Zhao, Wei-Feng Yuan

Machine Learning-Based Segmentation of Left Ventricular Myocardial Fibrosis from Magnetic Resonance Imaging

Fatemeh Zabihollahy, S. Rajan, E. Ukwatta

The PASCAL Device—Early Experience with a Leaflet Approximation Device: What Are the Benefits/Limitations Compared with the MitraClip?

  • Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Noé Corpataux, Mirjam Gauri Winkel, Mohammad Kassar, Nicolas Brugger, Stephan Windecker, Fabien Praz

Echo-Guided Pericardiocentesis: When and How Should It Be Performed?

Nir Flint, Robert J. Siegel

Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets

  • Open Access
  • Statins
  • Lipid Abnormalities and Cardiovascular Prevention (Section Editors)

Lluís Masana, Daiana Ibarretxe, Núria Plana

Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?

  • Hypertriglyceridemia
  • Lipid Abnormalities and Cardiovascular Prevention (G. De Backer, Section Editor)

Michel R. Langlois, Allan D. Sniderman

Remote Physiologic Monitoring for Heart Failure

Omaima Ali, Alexander G. Hajduczok, John P. Boehmer

Appropriate Use Criteria for Echocardiography in the Era of Value-Based Care: Mission Accomplished or Future Mandates?

Ian Hackett, R. Parker Ward

Disorders of the Aorta and Aortic Valve in Connective Tissue Diseases

Bogna Grygiel-Górniak, Mary-Tiffany Oduah, Abdulbaril Olagunju, Michal Klokner

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME